Healthcare Services

Omeprazole Market Expected to Record Steady Growth and Approach $3.46 Billion by 2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Omeprazole Market During The Forecast Period 2026–2030?

The omeprazole market has witnessed substantial growth over recent years. Its value is forecast to increase from $2.5 billion in 2025 to $2.68 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.3%. Historically, this expansion can be attributed to several factors including the rising prevalence of gastric and duodenal ulcers, an increase in cases of gastroesophageal reflux disease (gerd), greater awareness of proton pump inhibitors, the restricted availability of alternative therapies, and the broadening reach of hospital and retail pharmacy networks.

The omeprazole market is anticipated to undergo significant expansion in the next few years, with projections indicating it will climb to $3.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This growth throughout the forecast period stems from factors such as increasing demand for customized gastric treatments, the proliferation of online pharmacy channels, advancements in drug delivery systems, wider acceptance of omeprazole for pediatric and geriatric populations, and the expansion of pharmaceutical manufacturing in emerging markets. Prominent trends expected during this period include a rise in the adoption of digital health platforms for prescription management, the integration of artificial intelligence into drug formulation and personalized therapy, the evolution of precision medicine approaches for gastrointestinal disorders, automation in pharmaceutical manufacturing and quality control processes, and IoT-enabled monitoring for drug storage and distribution.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16495&type=smp

What Drivers Are Expected To Influence The Omeprazole Market During The Forecast Period?

A rising occurrence of gastric cancers is anticipated to fuel the expansion of the omeprazole market in the foreseeable future. Gastric cancers are defined as malignant growths that originate within the stomach’s lining. This increased incidence of gastric cancers is attributed to several factors, including chronic Helicobacter pylori infection, significant alcohol consumption, genetic predisposition, long-term gastritis, obesity, and regional variations in prevalence. Omeprazole, a proton pump inhibitor, contributes to the management of gastric cancers by reducing the production of stomach acid, which in turn can alleviate symptoms, enhance quality of life, and promote the healing of ulcers or lesions found in the stomach lining. For example, in January 2025, the American Cancer Society (ACS), a US-based health organization, reported approximately 30,300 new cases of gastric cancer, with 17,720 cases in men compared to 12,580 cases in women, indicating that men are affected more frequently than women. Similarly, of the nearly 10,780 deaths from this cancer, 6,400 were men and 4,380 were women, demonstrating a higher mortality burden among men. Consequently, the increasing incidence of gastric cancers is serving as a driver for the omeprazole market.

What Market Segments Are Evaluated Within The Omeprazole Market?

The omeprazole market covered in this report is segmented –

1) By Dosage Form: Capsule, Powder, Tablet

2) By Indication: Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Capsule: Delayed-Release Capsules, Immediate-Release Capsules

2) By Powder: Oral Suspension Powder, Injectable Powder

3) By Tablet: Delayed-Release Tablets, Immediate-Release Tablets

What Key Developments And Trends Are Impacting The Omeprazole Market?

Leading companies within the omeprazole market are focusing on developing ready-to-use liquid formulations to significantly improve patient convenience and compliance, particularly benefiting individuals who experience difficulty in swallowing tablets or capsules. These liquid omeprazole formulations offer several advantages, including enhanced patient compliance, greater convenience, precise dosing, a quicker onset of action, and improved medication stability. For example, in February 2024, Alkaloid AD, a pharmaceutical manufacturing firm based in North Macedonia, introduced its liquid Omeprazole. This product stands as the first ready-to-use liquid Omeprazole specifically designed for patients suffering from reflux esophagitis and GERD who cannot swallow tablets, featuring an innovative dual-chamber package. This development provides a more practical and accessible treatment alternative for patient demographics such as young children, adult patients with dysphagia, individuals with gastric feeding tubes, and geriatric patients, all of whom face challenges in swallowing traditional tablets or capsules. The company has secured the initial international patent for a value-added medicine (VAM) for this product and has successfully obtained marketing authorizations for both the Macedonian and UK markets.

Who Are The Top Market Participants Influencing The Omeprazole Market?

Major companies operating in the omeprazole market are Pfizer Inc., AstraZeneca plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited

Read the full omeprazole market report here:

https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report

Which Region Is Forecast To Lead The Omeprazole Market In Terms Of Market Size?

North America was the largest region in the omeprazole market in 2025. The regions covered in the omeprazole market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omeprazole Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16495&type=smp

Browse Through More Reports Similar to the Global Omeprazole Market 2026, By The Business Research Company

Oligonucleotides Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Gene Synthesis Global Market Report

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Peptide Synthesis Global Market Report

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795